Collagen Solutions PLC (LON:COS) has been granted additional patent protecttion in Australia for the ultra-thin processed pericardium tissue for heart valve replacement and other uses.
New Zealand and Australia are the first choice for animal-based biomaterials, said Collagen, and the countries have been supplying material under strict controls for decades.
WATCH: Collagen boss hails additional patent ...
The divisional patent will allow Collagen to source materials from within Australia and also protect its proprietary knowledge in the supply and development of pericardium-based tissues.
Jamal Rushdy, chief executive, said: "Our pericardium tissue business has been growing and has promising potential in cardiovascular and other markets including general surgery, orthopaedics, wounds, and dental.
“This recent patent further strengthens our position in sourcing tissue in Australia in a novel way.
“We believe the additional processing covered in this patent will be of significant interest to our existing customer base".